Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer
NCT03430479
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Cohort A
Sponsor
Kyoto Breast Cancer Research Network